People · Operator
Named in public records as an officer, director or promoter · active 2007–2025 · Space / Aerospace, Biotechnology, Pharmaceuticals, Healthtech, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Space Exploration Technologies Corp | — | Space / Aerospace | Growth/Late | $9.0B | $4.4B | 2015 |
| Castle Creek Biosciences, Inc. | — | Biotechnology | Growth/Late | $839.8M | $804.2M | 2018 |
| Paragon Biosciences Emalex Capital, Inc. | — | Pharmaceuticals | Series D+ | $376.8M | $5.5B | 2019 |
| K Health, Inc. | — | Healthtech | Series D+ | $353.4M | $915.1M | 2021 |
| Harmony Biosciences II, Inc. | — | Pharmaceuticals | Series D+ | $345.0M | $1.8B | 2017 |
| Tesla, Inc. | — | Other Technology | Series D+ | $246.6M | $632.7M | 2007 |
| Porch.com, Inc. | — | Other | Series C | $115.4M | $353.6M | 2015 |
| Bird Rides, Inc. | — | Other | Series C | $94.7M | $1.6B | 2018 |
| Cloud9 Esports, Inc. | — | Gaming | Series C | $79.5M | $26.5M | 2018 |
| keenwawa, inc. | — | Other Technology | Series C | $67.0M | $515.8M | 2019 |
| Magic School, Inc. | — | Edtech | Series C | $64.6M | $295.8M | 2025 |
| Castle Creek Pharmaceuticals, LLC | — | Pharmaceuticals | Series C | $48.0M | $1.7B | 2016 |
| Fooda, Inc. | — | Business Services | Series A | $32.5M | $4.5M | 2013 |
| Harbor Platform, Inc. | — | Software / Tech | Series B | $28.3M | $860.4M | 2018 |
| CIRC Biosciences, Inc. | — | Biotechnology | Series B | $24.1M | $54.6M | 2024 |
Antonio Gracias at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Antonio Gracias on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey Aronin | 5 | 6 |
| Patrick Morris | 5 | 6 |
| Antonio J. Gracias | 4 | 7 |
| Timothy Cunniff | 4 | 5 |
| Darien Parhad | 4 | 4 |
| Patrick J. Morris | 3 | 8 |
| Jonathan Shulkin | 2 | 17 |
| DAVID SACKS | 2 | 12 |
| Steve Jurvetson | 2 | 10 |
| Darien J. Parhad | 2 | 7 |
| Jonathan K. Shulkin | 2 | 6 |
| Elon Musk | 2 | 6 |
| Michael Derby | 2 | 5 |
| Kimbal Musk | 2 | 5 |
| Juan Sabater | 2 | 4 |
| Jeffrey S. Aronin | 2 | 4 |
| Steve R Jurvetson | 2 | 3 |
| Timothy M. Cunniff | 2 | 2 |
| Nigel K. Travis | 2 | 2 |
| Jack Nielsen | 1 | 13 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.